ScholarGate
Asistents

Salīdzināt metodes

Apskatiet izvēlētās metodes blakus; rindas, kas atšķiras, ir izceltas.

Instrumentālo mainīgo (IV) metode cēloņsakarību noteikšanai×Markova ķēdes modelis veselības ekonomikas jomā×
NozareVeselības ekonomikaVeselības ekonomika
SaimeProcess / pipelineProcess / pipeline
Izcelsmes gads1990s (modern applications)1983
AutorsAngrist & Pischke (applied econometrics); rooted in econometric theoryBeck & Pauker (medical decision analysis, Massachusetts General Hospital)
TipsMethodMethod
PirmavotsAngrist, J. D., & Pischke, J. S. (2009). Mostly Harmless Econometrics: An Empiricist's Companion. Princeton: Princeton University Press. link ↗Beck, J. R., & Pauker, S. G. (1983). The Markov Process in Medical Prognosis. Medical Decision Making, 3(4), 419-458. DOI ↗
Citi nosaukumiIV, two-stage least squares, TSLS, causal estimationMarkov model, state transition model, cohort simulation
Saistītās35
KopsavilkumsInstrumental variables (IV) is an econometric method to estimate causal effects when treatment or exposure is not randomly assigned and confounding is severe or unmeasured. IV relies on a third variable (instrument) that influences treatment but does not directly affect the outcome, allowing researchers to isolate the causal effect from the noise of confounding. Developed extensively in econometrics (Angrist & Pischke, 1990s–2000s), IV methods are increasingly used in health economics and health services research to leverage natural experiments and policy changes.A Markov model is a decision-analytic tool that simulates disease progression through defined health states over time, calculating cumulative costs and quality-adjusted life years (QALYs) to enable cost-effectiveness analysis. Developed by Beck and Pauker in 1983, Markov models are now the standard framework for projecting long-term outcomes of health interventions, especially chronic diseases where patients transition between clinical states (treatment response, disease progression, remission, death). Used by health technology assessment bodies and pharmaceutical companies to predict intervention value beyond trial duration.
ScholarGateDatu kopa
  1. v1
  2. 3 Avoti
  3. PUBLISHED
  1. v1
  2. 3 Avoti
  3. PUBLISHED

Doties uz meklēšanu Lejupielādēt slaidus

ScholarGateSalīdzināt metodes: Instrumental Variables in Health Research · Markov Model in Health Economics. Izgūts 2026-06-20 no https://scholargate.app/lv/compare